BLOCK LISTING SIX MONTHLY RETURN
Omega Diagnostics Group Plc (the "Company") provides below the information required by Schedule Six of the AIM Rules for Companies in connection with the unexercised warrants issued pursuant to the Company's capital fundraise announced 6 May 2022 ("Warrants").
Date: 10 May 2023
| Name of applicant: | Omega Diagnostics Group PLC | |||
| Name of scheme: | Unexercised Warrants, pursuant to the Company's capital fundraise announced 6 May 2022. | |||
| Period of return: | From: | 23 March 2023 | To: | 10 May 2023 |
| Balance of unallotted securities under scheme(s) from previous return: | Warrants: 90,000,000 warrants over ordinary shares of 4p each ("Ordinary Shares") | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Warrants: nil | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | Warrants: nil | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | Warrants: 90,000,000 Ordinary Shares | |||
| Name of contact: | Chris Lea, Company Secretary |
| Telephone number of contact: | 020 7933 8780 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.